logo-loader
AIM:ETX

e-Therapeutics PLC

Receive alerts
Market:
AIM
Market Cap:
£56.84 m
Price
13.56 GBX
Change
-0.46%
52 weeks high
23.00
52 weeks low
1.25

In brief

We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique network-driven drug discovery ("NDD") methodology which allows us to discover novel and better drugs faster.

Deep dive We explore the investor case for growth companies

Snapshot

  • Network-driven platform helps expedite the drug discovery process
  • Denmark's Novo Nordisk uses the platform for new diabetes drugs
  • Two cancer programmes of its own
  • Ali Mortazavi now executive chairman